• Español
855.975.5119Member Login
Cano Health
  • Find a Location
    • All Cano Health
    • Florida
    • California
    • Illinois
    • Nevada
    • New Mexico
    • Puerto Rico
    • Texas
  • Primary Care
    • Transportation
    • FAQ
  • Wellness
  • Pharmacy
  • About
    • Message from CEO
    • Executive Team
    • Investors
    • News
    • Blog
    • Population Health
  • Contact Us
  • Search
  • Menu

Research Today for A Better Tomorrow

Who we are

Cano Research is the clinical research arm of Cano Health that focuses on providing new and innovative treatments and diagnostic tests for our patients. We also provide opportunities for our patients to participate in academic and outcomes-based research in our network.

Why Cano Research

The patient population at Cano Health is largely diverse and allows Cano Research to attract studies that are tailored to the most common diseases in our patient population.

Phase II

Phase II trials involve more participants than Phase I trials and are designed to test both the safety and effectiveness of new treatments. These trials are instrumental to the development of cutting-edge treatments and form a part of the clinical studies portfolio of Cano Research.

Phase III

Phase III studies are the final step before seeking regulatory approval for a new treatment from organizations like the Food & Drug Administration (FDA). These trials include large populations of patients and can last multiple years. During Phase III trials, scientists, also called investigators both identify any side effects that were not observed during the Phase II trial, as well as examine the efficacy of the investigational treatment against the current standard of care.

Phase IV

Phase IV clinical trials are long-term safety and efficacy trials that occurs after the investigational treatment has been approved by the FDA.

Clinical Trials

We conduct phase II-IV trials for five vital diseases:

Clinical subjects at Cano Research have access to a wide array of clinical trials. Cano Health physicians serve as investigators for both Phase II and Phase III clinical trials for the following disease states:

  • Cardiovascular Disease
  • Alzheimer’s and Dimentia
  • Diabetes Mellitus
  • Lung Cancer
  • Obesity

Cardiovascular Disease

Alzheimer’s and Dementia

Diabetes Mellitus

Lung Cancer

Obesity

Let’s work together

If you’re interested in working with us, fill the form out and we will get in contact with your company. Please make sure to leave the name, number, and email of the person we can contact regarding this information.

Company Address
Do you have additional comments?

Contact Cano Research for More Information and Upcoming Trials

754.237.1075
FIND A LOCATION

California

Florida

Texas

Illinois

Nevada

New Mexico

Puerto Rico

ABOUT US

Our Mission

Executive Team

Cano Care

Careers

News

Blogs

FAQs

CORPORATE

9725 NW 117 Ave

Miami, FL 33178

855.975.5119

Investors

Privacy Policy

Notice of Privacy Practices

Media Relations

Cano Health news delivered to your inbox

Connect with us through our newsletter to get helpful health-related tips and information.

© Cano Health. All rights reserved.

Scroll to top